IP Library Granted Patent US 10,799,530
Granted Patent B1
US 10,799,530 · App. 16/722,167 · Granted Oct 13, 2020

Composition and method for the prevention and treatment of obesity

Inventors: Peter Novak (Sunny Isles Beach, FL); Maxim Temnikov (Miami, FL); Oleksandr Balakin (Dnepropetrovsk, UA)
Assignee: Vector Vitale IP LLC
A61K33/30A61K9/0019A61K9/0053A61K31/197
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,799,530
App. No.
16/722,167
Granted
Oct 13, 2020
Kind
B1
Abstract

A method for reducing the weight of an overweight or obese subject comprising administering a therapeutically effective amount of a composition comprising 64 Zn-enriched zinc. A method for preventing or reducing weight gain comprising administering an effective amount of a composition comprising 64 Zn-enriched zinc.

Claims (11)

1. A method of treating overweightness or obesity comprising administering to a subject in need thereof a therapeutically effective amount of a composition comprising a 64 Zn e compound or a salt thereof, wherein the 64 Zn e compound or a salt thereof is at least 80% 64 Zn e .

2. The method of claim 1 , wherein the composition further comprises a diluent or an excipient.

3. The method of claim 2 , wherein the diluent is deuterium-depleted water.

4. The method of claim 1 , wherein the 64 Zn e compound or a salt thereof is at least 95% 64 Zn e .

5. The method of claim 1 , wherein the 64 Zn e compound or a salt thereof is at least 99% 64 Zn e .

6. The method of claim 1 , wherein the composition contains between 0.05 mg and 110 mg of 64 Zn e .

7. The method of claim 6 , wherein the composition contains between 1 and 10 mg of 64 Zn e .

8. The method of claim 1 , wherein the 64 Zn e compound or a salt thereof is at least 90% 64 Zn e and the composition is an aqueous solution in which 64 Zn e is present at a concentration of between 0.1 mg/ml and 10 mg/ml.

9. The method of claim 1 , wherein 64 Zn e is in a form of salt selected from the group consisting of asparaginate (chemical formula—C 4 H 5 O 4 N 64 Zn e ) with 2 aspartic acid molecules, sulfate, and citrate.

10. The method of claim 1 , wherein the composition is administered by injection.

11. The method of claim 1 , wherein the composition is administered orally.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2020
From: BALAKIN, OLEKSANDR
To: NOVAK, PETER Y.; TEMNIKOV, MAXIM V.
Reel/Frame 052676/0963 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2020
From: NOVAK, PETER Y.; TEMNIKOV, MAXIM V.
To: VECTOR VITALE IP LLC
Reel/Frame 052677/0049 →
Cited By (3)
US 12,233,089 US 12,527,819 US 12,734,240